Esfandiarpour, Iraj <br/><br/>
Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis.  [electronic resource] 

 -  International journal of dermatology  Oct 2012 
 - 1221-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-4632 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-4632.2012.05460.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anaphylaxis--chemically induced<br/>Antiprotozoal Agents--adverse effects<br/>Child<br/>Child, Preschool<br/>Cross-Sectional Studies<br/>Erythema--chemically induced<br/>Female<br/>Humans<br/>Infant<br/>Injections, Intralesional--adverse effects<br/>Iran<br/>Leishmaniasis, Cutaneous--blood<br/>Male<br/>Meglumine--adverse effects<br/>Meglumine Antimoniate<br/>Middle Aged<br/>Organometallic Compounds--adverse effects<br/>Pain--chemically induced<br/>Pruritus--chemically induced<br/>Treatment Outcome<br/>Vomiting--chemically induced<br/>Young Adult